Ionis Pharmaceuticals (IONS) Asset Utilization Ratio (2010 - 2026)

Ionis Pharmaceuticals' Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.17 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 29.28% year-over-year to 0.17; the TTM figure through Mar 2026 stood at 0.17 (down 29.28% YoY), while the FY2025 annual figure was 0.29, up 22.89% from the prior year.
• Asset Utilization Ratio was 0.17 for Q1 2026 at Ionis Pharmaceuticals, up from 0.15 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.36 in Q3 2022 to a low of 0.15 in Q4 2025.
• Historically, Asset Utilization Ratio has averaged 0.24 across 5 years, with a median of 0.24 in 2022.
• The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio jumped 133.23% in 2022, then slumped 42.86% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.24 in 2022, then rose by 12.18% to 0.27 in 2023, then fell by 12.84% to 0.23 in 2024, then sank by 35.03% to 0.15 in 2025, then grew by 15.83% to 0.17 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.17 (Q1 2026), 0.15 (Q4 2025), and 0.17 (Q3 2025), per Business Quant data.